title: Ophthalmoscopic assessment of the retinal nerve fiber layer. The Beijing Eye Study.
abstract: OBJECTIVE
  To examine the retinal nerve fiber layer (RNFL) ophthalmoscopically, to search for localized RNFL defects, and to assess factors associated with RNFL visibility in a population-based setting.
  
  
  METHODS
  The population-based cross-sectional Beijing Eye Study 2006 included 3251 subjects. Using color fundus photographs, RNFL visibility was assessed in grades from 0 to 8 in 8 fundus sectors. Localized RNFL defects were defined as wedge-shaped defects running towards the optic disc.
  
  
  RESULTS
  After exclusion of subjects with optic media opacities, 2602 subjects (mean age: 58.1±9.0 years) were included. RNFL visibility score was highest (P<0.001) in the temporal inferior region, followed by the temporal superior region, nasal superior region, and nasal inferior region. In multivariate analysis, higher RNFL visibility score was associated with younger age (P<0.001; standardized coefficient beta: -0.44; regression coefficient B: -0.22; 95%CI: -0.24, -0.20), female gender (P<0.001; beta: 0.11; B: 1.00; 95%CI: 0.67, 1.32), higher blood concentration of low-density lipoproteins (P = 0.002; beta: 0.07; B: 0.34; 95%CI: 0.13, 0.56), absence of dyslipidemia (P = 0.001; beta: -0.07; B: -0.58; 95%CI: -0.93, -0.24), lower blood glucose concentration (P = 0.006; beta: -0.05; B: -0.14; 95%CI: -0.24, -0.04), hyperopic refractive error (P<0.001; beta: 0.15; B: 0.45; 95%CI: 0.34, 0.56), smaller optic disc size (P<0.001; beta: -0.08; B: -0.72; 95% CI: -1.04, -0.40), absence of glaucomatous optic neuropathy (P<0.001; beta: -0.06; B: -2.69; 95%CI: -4.18, -1.21) and absence of non-glaucomatous optic nerve damage (P = 0.001; beta: -0.06; B: -4.80; 95%CI: 0. -7.64, -1.96). Localized RNFL defects were detected in 96 subjects (prevalence:3.7±0.45% (95% confidence interval (CI): 3.0, 4.4). In multivariate analysis, prevalence of localized RNFL defects was associated with higher blood pressure (P<0.001; odds ratio (OR): 1.07; 95%CI: 1.03, 1.10), higher concentration of low-density lipoproteins (P = 0.01; OR: 1.42; 95%CI: 1.08, 1.85), higher prevalence of glaucomatous optic neuropathy (P<0.001; OR: 46.8; 95%CI: 19.4, 113) and diabetic retinopathy (P = 0.002; OR: 3.20; 95%CI: 1.53, 6.67), and lower total RNFL visibility (P<0.001; OR: 0.92; 95%CI: 0.88, 0.96).
  
  
  CONCLUSIONS
  In Chinese aged 45+ years, a decreased RNFL visibility was associated with older age, male gender, dyslipidemia, hyperglycemia, myopia, larger optic disc, and glaucomatous or non-glaucomatous optic neuropathy. Localized RNFL defects (prevalence: 3.7±0.45%) were correlated mainly with higher blood pressure, higher concentration of low-density lipoproteins, glaucomatous optic neuropathy and diabetic retinopathy. These data are helpful for the routine ophthalmoscopic examination of the RNFL.
authors: Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
authors: Yaqin
authors: Y
authors: Zhang
authors: Liang
authors: L
authors: Xu
authors: Li
authors: L
authors: Zhang
authors: Hua
authors: H
authors: Yang
authors: Ya Xing
authors: YX
authors: Wang
authors: Jost B
authors: JB
authors: Jonas
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002681:China; D003430:Cross-Sectional Studies; D005128:Eye Diseases / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009412:Nerve Fibers / Q000473:pathology / Q000502:physiology*; D009887:Ophthalmoscopy; D012160:Retina / Q000166:cytology* / Q000473:pathology / Q000502:physiology* / Q000503:physiopathology
references: Invest Ophthalmol Vis Sci. 1991 Feb;32(2):401-5
references: 1993592
references: Eye (Lond). 1987;1 ( Pt 5):621-5
references: 3446544
references: Graefes Arch Clin Exp Ophthalmol. 1993 Apr;231(4):207-11
references: 8486301
references: Am J Ophthalmol. 1984 Nov;98(5):566-71
references: 6496612
references: Invest Ophthalmol Vis Sci. 1988 Jul;29(7):1151-8
references: 3417404
references: Am J Hypertens. 2013 Apr;26(4):511-7
references: 23429477
references: Br J Ophthalmol. 1972 Aug;56(8):577-83
references: 5079403
references: Br J Ophthalmol. 2002 Feb;86(2):238-42
references: 11815354
references: Arch Ophthalmol. 1977 Dec;95(12):2149-56
references: 588106
references: Am J Ophthalmol. 2006 Nov;142(5):788-93
references: 16989759
references: Ophthalmology. 1989 May;96(5):627-32
references: 2748120
references: Ophthalmology. 1990 Mar;97(3):358-65; discussion 365-6
references: 2336274
references: Graefes Arch Clin Exp Ophthalmol. 1994 Dec;232(12):759-60
references: 7890191
references: Invest Ophthalmol Vis Sci. 1992 May;33(6):2012-8
references: 1582806
references: Ophthalmology. 2009 Apr;116(4):732-8
references: 19195709
references: Acta Ophthalmol (Copenh). 1981 Oct;59(5):627-41
references: 7315218
references: Surv Ophthalmol. 1996 Mar-Apr;40(5):369-78
references: 8779083